News Medical1d
Younger age at type 2 diabetes diagnosis increases mortality risk
Research found that younger age at type 2 diabetes diagnosis is associated with higher risks of cardiovascular and all-cause ...
Amgen's Phase 2 Results Were Not Bad, Don't Let Mr. Market Fool You
Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.
Too Old to Operate2d
Higher Stroke and Mortality Risk in Patients With High-Risk TIA Scores
The following is a summary of “Incident Stroke After First-Time TIA According to ABCD2 Score: A Nationwide Cohort Study,” published in the November 2024 issue of Neurology by Al-Chaer et al. A ...